{"id":9983,"date":"2025-08-12T17:55:23","date_gmt":"2025-08-12T09:55:23","guid":{"rendered":"https:\/\/www.excelsiormedical.com.tw\/?p=9983"},"modified":"2025-08-26T15:41:24","modified_gmt":"2025-08-26T07:41:24","slug":"the-board-of-directors-approved-q2-2025-consolidated-financial-statements","status":"publish","type":"post","link":"https:\/\/www.excelsiormedical.com.tw\/en\/investors\/the-board-of-directors-approved-q2-2025-consolidated-financial-statements\/","title":{"rendered":"The Board of Directors approved Q2 2025 consolidated financial statements."},"content":{"rendered":"

 <\/p>\n\n\n\n\n\n\n
SEQ_NO<\/td>\n\u00a01<\/td>\nDate of announcement<\/td>\n2025\/08\/12<\/td>\nTime of announcement<\/td>\n17:55:28<\/td>\n<\/tr>\n
Subject<\/td>\n\n
The Board of Directors approved Q2 2025\r\nconsolidated financial statements.<\/pre>\n<\/td>\n<\/tr>\n
Date of events<\/td>\n2025\/08\/12<\/td>\nTo which item it meets<\/td>\nparagraph 31<\/td>\n<\/tr>\n
Statement<\/td>\n\n
1.Date of submission to the board of directors or approval by the board of\r\ndirectors:2025\/08\/12\r\n2.Date of approval by the audit committee:2025\/08\/12\r\n3.Start and end dates of financial reports or annual self-assessed financial\r\ninformation of the reporting period (XXXX\/XX\/XX~XXXX\/XX\/XX):\r\n2025\/01\/01~2025\/06\/30\r\n4.Operating revenue accumulated from 1\/1 to end of the period\r\n(thousand NTD):4,316,974\r\n5.Gross profit (loss) from operations accumulated from 1\/1 to end of\r\nthe period (thousand NTD):924,167\r\n6.Net operating income (loss) accumulated from 1\/1 to end of the period\r\n(thousand NTD):381,463\r\n7.Profit (loss) before tax accumulated from 1\/1 to end of the period\r\n(thousand NTD):629,394\r\n8.Profit (loss) accumulated from 1\/1 to end of the period\r\n(thousand NTD):513,365\r\n9.Profit (loss) during the period attributable to owners of parent\r\naccumulated from 1\/1 to end of the period (thousand NTD):425,065\r\n10.Basic earnings (loss) per share accumulated from 1\/1 to end of\r\nthe period (NTD):2.60\r\n11.Total assets end of the period (thousand NTD):18,429,283\r\n12.Total liabilities end of the period\r\n(thousand NTD):7,625,652\r\n13.Equity attributable to owners of parent end of the\r\nperiod (thousand NTD):8,486,033\r\n14.Any other matters that need to be specified:None.<\/pre>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"
  SEQ_NO \u00a01 Date of announcement 2025\/08\/12 Time of announcement 17:55:28 Subject The Board of Directors approved Q2 2025 consolidated financial statements. Date of events 2025\/08\/12 To which item it meets paragraph 31 Statement 1.Date of submission to the board of directors or approval by the board of directors:2025\/08\/12 2.Date of approval by the audit …<\/p>\n
  The Board of Directors approved Q2 2025 consolidated financial statements.<\/span> Read More »<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[72,102],"tags":[],"class_list":["post-9983","post","type-post","status-publish","format-standard","hentry","category-investors","category-material-information"],"_links":{"self":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/9983","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/comments?post=9983"}],"version-history":[{"count":1,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/9983\/revisions"}],"predecessor-version":[{"id":9984,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/9983\/revisions\/9984"}],"wp:attachment":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/media?parent=9983"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/categories?post=9983"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/tags?post=9983"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}